Sexual dysfunction among postmenopausal Tunisian women
Ati, N1; Elati, Z2; Manitta, M3; Mnasser, A3; Zakhama, W3; Binous, MY3
1: departement of urology, Taher Sfar Hospital Mahdia, Tunisia; 2: departement of nephrology hemodialysis,Taher Sfar Hospital, Mahdia , Tunisia; 3: departement of urology, Taher Sfar Hospital, Mahdia , Tunisia
Objective(s): This study examined the relationship between quality of life (QoL) and sexual function among postmenopausal women.
Material and Method(s): This descriptive, cross-sectional study was conducted in 100 menopausal females aged between 50 and 72 years who are visiting urology or nephrology consultations.The data-collection tools were the Female Sexual Function Index (FSFI) questionnaire and the 36-Item Short Form Health Survey (SF-36) questionnaire.
Result(s): The mean age and standard deviation of the subjects was 58 ± 6 years. The median age of natural menopause was 46 years. This study revealed that the most common disease was found to be diabetes mellitus (20%), followed by hypertension (17%), renal failure (9%) and urinary stone disease (8%), and the majority of subjects (64%) had no specific disease. Women had a mean BMI of 25 kg/m2. The mean ± SD total score of FSFI was 18.8±8.7 (in the range of 2 to 36). As for the FSFI domains, the mean scores were 2.6±1.1 (0 to 6.0); 2.7±1.5 (0 to 6.0); 3.3±1.8 (0 to 6.0); 3.1±1.8 (0 to 6.0); 3.4±1.6 (0 to 6.0) and 3.6±2.0 (0 to 6.0) respectively for desire, arousal, lubrification , orgasm, satisfaction and pain domains. Female sexual dysfunction was observed in 62 % of the participants (FSFI ≤ 26.55). The number of children living with the couple, doctor/patient relationship and the interest of doctors in postmenopausal women’s sexuality was significantly associated with FSFI score.
Conclusion(s): A negative impact of sexual dysfunction on the quality of life was reported by 70%. The mean score of SF-36 was 74. The scores of vitality and mental health items were significantly altered. There was a negative correlation between FSFI subdimension and total SF-36 score (p=0,01).
Conclusion: The findings of this analysis may help clinicians about expectations and treatment options to address menopause-associated sexual disorder and the relationship between postmenopausal sexual disorder and overall health.
Work supported by industry: no.Go Back